genotype directed antiplatelet therapy, is the time right?
Published 2 years ago • 1.4K plays • Length 47:23Download video MP4
Download video MP3
Similar videos
-
16:47
tailor-pci and the role of genotype-guided antiplatelet therapy
-
10:31
entering the twilight zone of dapt duration
-
0:40
ccd guideline - antiplatelet therapy
-
11:05
cyp2c19-guided antiplatelet therapy after pci
-
22:20
gm10: clopidogrel - larisa cavallari
-
30:07
the changing face of dual anti-platelet therapy: implications for the internist
-
3:01
antiplatelet therapy post percutaneous coronary intervention by peter m. pollak, md | preview
-
24:11
the personalization of clopidogrel antiplatelet therapy
-
5:54
combining antiplatelet and anticoagulant therapies
-
7:14
acs management following dual antiplatelet therapy
-
34:57
a look into the future of antiplatelet therapy
-
13:05
guideline recommendations for antiplatelet therapy and evidence gap - schuyler jones, md
-
2:58
lumbar puncture and dual antiplatelet therapy
-
5:51
acc 2018: anti-platelet therapy in pci - adapt
-
35:26
current state of antiplatelet therapy
-
23:25
(board review) - antiplatelet therapy - dr. sweeny
-
20:34
onyx one: aspirin vs. p2y12 after 1-month dual antiplatelet therapy for high bleeding risk patients
-
9:43
optimal duration of dual antiplatelet therapy - video review
-
36:21
platelet reactivity testing round table discussion session 1